WeChatshare
7th BioCon China 2020 & Biotechnology Equipment and  Reagent Exhibition

You can share it to WeChat via the Qr code.

Eventsshare
7th BioCon China 2020 & Biotechnology Equipment and  Reagent Exhibition

Enter the applet sharing event using WeChat scan.

July 8

Novel Antibody Engineering & Discovery

What you will learn:

★ New targets of antibody and transformation progress

 Experience of design new antibody sequences

 New toxin and coupling strategy of ADC

 Druggability of novel antibody

Who would attend:

 Management of biopharmaceutical and biotechnology companies: Head of early R&D, mechanism research, drug discovery, project survey department

 PI from Universities, research institutions and hospitals: Scientist majored in pharmacy, translational medicine, biology and life science


Cell Therapy CMC Research

What you will learn:

★ Latest interpretation of CMC review for cell therapy

 Constructing production specifications and quality system for cell therapy and virus

 Requirements of quality analysis and control for cell therapy drug release

 Optimization strategies for upstream, downstream and preparation of cell therapy drug to shorten and simplify the process

Who would attend:

 Head of CMC, process development, quality research/analysis, manufacturing and technology department from cell therapy companies

 Head of process development, manufacturing, technology and quality analysis department from CDMO


Regulation and Design of Biopharma Clinical Trials

What you will learn:

Latest preclinical and clinical requirements and guidelines after entering ICH

 Latest policy of ethics, genetics office and new clinical operation strategies

 Experience about how to build a leading clinical quality management system

 Application of cutting-edge clinical analysis methods and clinical data management technologies

Who would attend:

 Head of preclinical R&D, pharmacology, toxicology, clinical R&D, clinical medicine, clinical operation and bioanalysis department from biopharmaceutical companies

 Head of clinical quality, RA department from biopharmaceutical companies

 HCP, doctors from clinical trial companies, CRC

 Supervisor and regulator


Novel Antibody Upstream Bioprocessing

What you will learn:

★ Process development and amplification of perfusion in upstream

 Optimization strategies of cell bank and medium

 Continuous integrated process in upstream and downstream

 Characterization and optimization of upstream fermentation process to increase yield and shorten process

Who would attend:

 Head of cell line construction and cell culture department

 Head of upstream process development department

 Head of upstream process amplification department

 Head of pilot scale upstream process development department

 Head of production technology department


Novel Antibody Downstream Bioprocessing

What you will learn:

★ Downstream purification process of new complex antibody

 Application of continuous technology in downstream purification

 Identification and removal process of new antibody related impurities

 Amplification of high-throughput purification process and key points of quality control

Who would attend:

 Head of downstream process development department

 Head of downstream process development department

 Head of pilot-scale downstream process development department

 Head of coupling and assembly

 Head of preparation department

 Head of quality analysis department


Modified Recombinant Protein R&D

What you will learn:

★ Experience of platform development for recombinant proteins

 R&D strategy for recombinant proteins’ long effectiveness

 R&D of new generation domestic cytokines, insulin and peptide drugs

Who would attend:

 Head of R&D department from biopharmaceutical and biotechnology companies working on recombinant proteins


BioManufacturing and Quality Management

What you will learn:

★ Requirements of quality for BLA tracking and reporting

 Constructing GMP quality system for production of international biologics

 Design and construction of biopharmaceutical plant

 Cutting-edge biopharmaceutical production strategy and experience of risk control and management

Who would attend:

 Management of biopharmaceutical and biotechnology companies working on cell therapy

 Head of manufacturing, technology and QA/QC department from biopharmaceutical companies

 Head of manufacturing, technology and QA/QC department from CDMO